BCR signaling plays a crucial role in the pathogenicity of CLL and is important for the maintenance of CLL cells (Burger & Chiorazzi, 2013; Schmid et al, 2022). This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.